Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.

Hsu, VM; Denton, CP; Domsic, RT; Furst, DE; Rischmueller, M; Stanislav, M; Steen, VD; ... Hough, DR; + view all Hsu, VM; Denton, CP; Domsic, RT; Furst, DE; Rischmueller, M; Stanislav, M; Steen, VD; Distler, JHW; Korish, S; Cooper, A; Choi, S; Schafer, PH; Horan, G; Hough, DR; - view fewer (2017) Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study. J Rheumatol 10.3899/jrheum.161040 . (In press).

http://ift.tt/2hIGLu4